Found 10 matching trials
SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects
PHASE1The purpose of this study is to evaluate the safety, tolerability, and phar...
Multiple Dose Ethnobridging PK Study in Healthy Subjects
PHASE1A Phase 1, double blind, placebo controlled, 4 cohort, multiple dose study ...
Location
Theravance Biopharma Investigational Site
Rifaximin in Patients With Diabetic Gastroparesis
PHASE2Researchers are trying to determine if subjects with diabetic gastroparesis...
Location
Mayo Clinic in Florida
Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
PHASE1This is a Phase 1, 2-part, open-label study. Part A will be a formulation b...
Location
Theravance Biopharma Investigational Site
TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
PHASE2A 3-Year Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety ...
Location
Theravance Biopharma Investigational Site
TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
PHASE1This is an open-label, 2-cohort study to evaluate the absolute bioavailabil...
Efficacy & Safety of TD-1473 in Ulcerative Colitis
PHASE2A Phase 2b/3 set of studies to evaluate the efficacy and safety of inductio...
Location
Theravance Biopharma Investigational Site
TD-1473 for Active Ulcerative Colitis (UC)
PHASE1This study is designed to evaluate the safety, tolerability, pharmacokineti...
Location
Theravance Biopharma Investigational Site
Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
PHASE1This is a Phase 1, open-label, 2-cohort, food-effect, DDI, and formulation ...
Efficacy and Safety of TD-1473 in Crohn's Disease
PHASE2A Phase 2 study to evaluate the efficacy, safety and tolerability of TD-147...
Location
Theravance Biopharma Investigational Site